NAD+ (500mg / 1000mg Vial) Dosage Protocol

Overview

NAD+ (nicotinamide adenine dinucleotide) is a critical coenzyme involved in cellular energy metabolism, DNA repair, and mitochondrial function. This educational protocol presents a once-daily subcutaneous approach with gradual titration for improved tolerability.

What is NAD+?

NAD+ is a coenzyme central to redox reactions, energy metabolism (glycolysis, TCA cycle, oxidative phosphorylation), and cellular maintenance pathways including DNA repair and mitochondrial biogenesis. Cellular NAD+ levels decline with age and metabolic stress, potentially contributing to reduced mitochondrial function and impaired cellular resilience.

Reconstitution Instructions

Standard Preparation (3 mL = 333.3 mg/mL concentration):

1. Allow lyophilized vial to reach room temperature before opening
2. Draw 3.0 mL bacteriostatic water (0.9% benzyl alcohol) with sterile syringe
3. Inject slowly down vial wall to avoid foaming; don’t aim directly at powder
4. Gently swirl or roll vial until powder fully dissolves (avoid vigorous shaking)
5. Solution should be clear and colorless; discard if discoloration appears
6. Label with reconstitution date and refrigerate at 2–8 °C (35.6–46.4 °F)
7. Use within 14 days; inspect before each use for clarity

Measurement Guide: Each 0.01 mL (1 unit on U-100 insulin syringe) = approximately 3.33 mg NAD+

Dosing Protocol

Gradual Titration Approach

Administration:
– Frequency: Once daily via subcutaneous injection
– Timing: Any consistent time of day; some prefer morning
– Duration: 8–16 weeks
– Start low to assess individual tolerance before escalating

Storage Instructions

Lyophilized (Unopened):
– Store at −20 °C (−4 °F) or below
– Ideally −80 °C for multi-year storage
– Keep in dry, dark environment
– Minimize moisture exposure (NAD+ powder is hygroscopic)

Reconstituted Solution:
– Refrigerate at 2–8 °C (35.6–46.4 °F)
– Use within approximately 14 days
– Protect from light (UV exposure degrades NAD+)
– Avoid repeated freeze-thaw cycles
– Discard if discoloration or precipitate develops

Supplies Needed (Per Protocol Duration)

For 8-week protocol:
– 6 NAD+ vials (1000 mg each)
– 56 U-100 insulin syringes
– 2 bottles bacteriostatic water (10 mL each)
– 2 boxes alcohol swabs (100-count)

For 12-week protocol:
– 8 vials
– 84 syringes
– 3 bottles bacteriostatic water
– 2 boxes alcohol swabs

For 16-week protocol:
– 11 vials
– 112 syringes
– 4 bottles bacteriostatic water
– 3 boxes alcohol swabs

Injection Technique

Preparation

– Wash hands thoroughly with soap and water
– Clean vial stopper with alcohol swab; allow to air-dry
– Select injection site and clean with alcohol swab
– Allow skin to air-dry completely before injecting

Needle Selection

– Use fine, short needle: 28–31 gauge insulin syringe
– Needle length: 5/16 to 1/2 inch (8–12 mm)
– Standard U-100 insulin syringes (1 mL capacity) are appropriate

Injection Procedure

– Pinch fold of skin between thumb and forefinger
– Insert needle at approximately 45° angle into pinched subcutaneous layer
– Do not aspirate for subcutaneous injections
– Depress plunger slowly over 5–10 seconds
– Wait a few seconds before withdrawing needle at same angle
– Apply clean cotton swab with light pressure
– Dispose of used needle in proper sharps container

Site Rotation

– Rotate systematically to prevent soreness and lipohypertrophy
– Alternate between left/right sides of abdomen or different quadrants
– Abdomen (2+ inches from navel) is common; outer thigh and upper arm are alternatives
– Choose areas with adequate subcutaneous tissue

How It Works

“Cellular NAD+ levels decline with age and metabolic stress” potentially contributing to reduced mitochondrial function. Clinical research has primarily used intravenous infusions at high doses (500–1,000 mg) for applications such as addiction treatment and acute metabolic support.

A pilot study demonstrated “750 mg NAD+ IV infusion over 6 hours was well‑tolerated in humans, with rapid metabolic clearance and no acute toxicity.” Subcutaneous injections at lower doses are emerging as practical alternatives for maintenance therapy.

Potential Benefits

Based on literature and case reports:

– May support cellular energy production and mitochondrial function through NAD+ pool replenishment
– Human case reports suggest benefits at 100–300 mg/day ranges for cognitive support and metabolic health
– High-dose IV protocols (500–1,500 mg daily for ~10 days) used in open-label studies for substance use disorder showed reports of reduced cravings and improved mood in follow-ups
– “No severe adverse events have been reported in published NAD+/NADH trials; side effects are generally mild”

Potential Side Effects

– High doses can produce adverse reactions such as insomnia, anxiety, or fatigue if escalated too quickly; gradual titration is advised
– Mild injection-site reactions (redness, itching, soreness) may occur with subcutaneous administration; typically resolve with site rotation
– Some individuals report transient headache or flushing; these effects are generally dose-dependent
– Doses exceeding ~200–300 mg/day should generally be reserved for supervised therapeutic use

Lifestyle Factors

Nutrition: Consume balanced diet rich in NAD+ precursors (niacin/vitamin B3, tryptophan) and support nutrients (B-vitamins, magnesium).

Exercise: Regular physical activity (resistance training and aerobic exercise) naturally upregulates cellular NAD+ biosynthesis and enhances mitochondrial adaptations.

Sleep: Prioritize 7–9 hours of quality sleep per night to support cellular repair processes and optimize circadian NAD+ metabolism.

Stress Management: Chronic stress depletes NAD+ pools; incorporate stress-reduction practices like meditation or yoga.

Alcohol: Alcohol metabolism consumes NAD+; moderate or eliminate alcohol intake during NAD+ protocols.

Important Notes

– Use new, sterile insulin syringes for each injection
– Rotate injection sites systematically to reduce soreness and prevent lipohypertrophy
– Clean both vial stopper and injection site with alcohol swabs
– Inject slowly over 5–10 seconds to minimize tissue irritation
– Document daily dose, injection site, and observed effects
– If persistent redness or lumps develop, apply hydrocortisone cream and rotate locations
– Starting at low doses (50 mg) is recommended to assess individual tolerance

Disclaimer

This content is intended for therapeutic educational purposes only and does not constitute medical advice, diagnosis, or treatment. NAD+ is provided for research use only and is not intended for human consumption. Always consult with a qualified healthcare professional before beginning any new supplementation or therapeutic protocol.